Nutrición en la esclerosis sistémica

Recasens, M.a Asunción; Puig, Celia; Ortiz-Santamaría, Vera

doi:10.1016/j.reuma.2011.09.006

Cited by 4 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nausea, vomiting, diarrhea, weight loss, severe constipation, and fecal incontinence, all may culminate in severe malnutrition [8-10]. This review discusses the approach to gastrointestinal disease management in SSc and is divided into sections addressing targeted therapies for different GI complications.…”

Section: Introductionmentioning

confidence: 99%

Management of Gastrointestinal Involvement in Scleroderma

Nagaraja

McMahan²,

Getzug³

et al. 2015

Curr Treat Options in Rheum

104

View full text Add to dashboard Cite

Gastrointestinal tract (GIT) commonly affects patients with systemic sclerosis (SSc). The GI involvement is quite heterogeneous varying from asymptomatic disease to significant dysmotility causing complications like malabsorption, weight loss and severe malnutrition. This review focuses on the management of GI involvement in SSc and has been categorized based on the segment of GIT involved. A brief discussion on the role of patient reported outcome measures in SSc-GI involvement has also been incorporated.

show abstract

Section: Introductionmentioning

confidence: 99%

Management of Gastrointestinal Involvement in Scleroderma

Nagaraja

McMahan²,

Getzug³

et al. 2015

Curr Treat Options in Rheum

104

View full text Add to dashboard Cite

show abstract

Esophageal Dysfunction in Systemic Sclerosis: An Update

Yan

et al. 2021

Rheumatol Ther

View full text Add to dashboard Cite

Esophageal motility disorders are prevalent in 90% of patients with systemic sclerosis [scleroderma (SSc)], with an increased mortality rate in patients with severe esophageal involvement. Esophageal smooth muscle damage caused by ischemia, nerve damage, and inflammatory factors may be responsible for discomfort and various complications in these patients. The clinical manifestations are diverse. Most hospitals still use traditional esophageal manometry and 24-h pH monitoring to diagnose esophageal function in patients with SSc. The aim of this review article is to provide an overview of SSc-related esophageal motility disorders and related research progress, including the pathogenesis and clinical features of these disorders and the progress made in endoscopic diagnosis. We also discuss the possible pathogenesis and potential therapeutic targets.

show abstract